Authentic Patient Scenarios
AI-enhanced patient scenarios based on authentic cases.
Live Zoom Webinar
1.00 CME/CE Credits
Reducing Nonadherence and Rehospitalization Through Effective Tardive Dyskinesia Treatment
Tardive Dyskinesia in Managed Care
Interactive and AI-enhanced education amplifying authentic patient voices through our collaboration with the National Organization for Tardive Dyskinesia, equipping managed care professionals to weigh the clinical and economic value of proper screening, diagnosis, and treatment of tardive dyskinesia with guideline-directed and evidence-based treatments.
DateAugust 12, 2026
Time4:00 PM EDT
FormatLive, Interactive Webinar
Why attend
Practical education built for managed care
Engage with realistic cases, evidence-based decision-making, and faculty discussion focused on improving TD care.
Interactive P&T Exercise
Participate in a mock Pharmacy & Therapeutics decision-making exercise.
Evidence-Based Decisions
Explore treatment selection and formulary decision-making using current evidence.
Live Faculty Discussion
Ask questions and engage directly with expert faculty during the live session.
Featured faculty
Learn from experienced clinical leaders
Leslie L. Citrome, MD, MPH
Clinical Professor, Psychiatry & Behavioral Sciences
New York Medical College – School of Medicine
Valhalla, New York
Mark Garofoli, PharmD, MBA, BCGP, CPE, CTTS
Clinical Associate Professor and Director of Experiential Learning
West Virginia University School of Pharmacy
Morgantown, West Virginia
Learning objectives
What participants will be able to do
1
Describe the physical, psychological, and socioeconomic impacts of TD symptoms along with the recommended monitoring guidelines for patients being treated with antipsychotics.
2
Describe the use of clinical tools for the assessment of TD across recommended patient populations.
3
Differentiate between guideline-recommended, FDA-approved first-line treatments and second-line options for TD based on the latest real-world evidence.
4
Construct population health management strategies that balance the economic impact of VMAT-2 inhibitors with long-term patient outcomes and reductions in total healthcare resource utilization.
Target Audience
This educational activity is intended for managed care pharmacists, physicians, nurse practitioners, physician assistants and other clinicians who manage TD.
Accreditation and Credit
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of PeerPoint Medical Education Institute and Real World CE. PeerPoint Medical Education Institute is accredited by the ACCME to provide continuing medical education for physicians.
PeerPoint Medical Education Institute designates the live format for this educational activity for a maximum of 1.00 AMA PRA Category 1 Credit™..
Physicians should only claim credit commensurate with the extent of their participation in the activity.
ACPE Accreditation
ACPE Requirements for Credit: Learners must correctly enter the six-digit evaluation code provided at the end of the webinar on the course page and complete the activity evaluation.
See introductory slides for more information on other credits provided.
- System Requirements: A computer or mobile device with audio, 4 GB RAM, a dual-core 2 GHz processor, and stable internet (600 kbps minimum; 1.2 Mbps recommended). Use the current Zoom app or Chrome 102+, Edge 102+, Firefox 105+, or Safari 16.4+.
- Questions regarding ACPE Accreditation: Contact support@achievece.com.
- Privacy Policy: Learner information is kept confidential and used only to administer the activity, award credit, and meet accreditation requirements. See our privacy policy here.
Reserve your spot today
Join us live on August 12, 2026 at 4:00 PM EDT for an interactive program focused on practical TD management in managed care.
Register for the Webinar